Learn about the mixed bag of alternatives for people who can’t afford GLP-1 weight loss drugs like Ozempic.

State spends $200M yearly on GLP-1 drugs Coverage for obesity treatment with Ozempic not allowed Lawmakers debate using cheaper compounded versions despite FDA concerns Contracts approved with new ...